Alvotech ALVO
NASDAQ ALVO
$5.20 +0.01 (+0.19%)
As of: Sep 9, 2026 · 1:24 PM EDT

Alvotech (ALVO) Operating Expenses (2021 - 2026)

Alvotech's (ALVO) quarterly Operating Expenses came in at -$65.4 million in Q2 2026, up 19.7% on a YoY basis from -$54.6 million in Q2 2025, and down 30.35% quarter-over-quarter from -$50.2 million in Q1 2026.

Analysis

Alvotech (ALVO) Operating Expenses (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Operating Expenses for 6 consecutive years, with -$65.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Expenses rose 19.7% year-over-year to -$65.4 million; the trailing twelve-month figure through Jun 2026 stood at -$331.4 million (up 22.16% YoY), and the FY2025 full-year result was -$275.1 million, down 16.08% from the prior year.
  • Operating Expenses declined to -$65.4 million in Q2 2026 per ALVO's latest filing, from -$50.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $593.4 million in Q2 2022 and bottomed at -$367.4 million in Q1 2022.
  • Historically, Operating Expenses has averaged -$113.1 million across 5 years, with a median of -$79.5 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Operating Expenses plunged 111.53% in 2023, then soared 77.26% in 2024.
  • Over 5 years, Operating Expenses stood at -$367.4 million in 2022, then advanced by 21.77% to -$287.4 million in 2023, then rose by 17.52% to -$237.0 million in 2024, then soared by 41.68% to -$138.2 million in 2025, then soared by 52.68% to -$65.4 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered -$65.4 million, -$50.2 million, and -$138.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Teva Pharmaceutical Industries 42.74 Bn 39.09 Bn 2.15 Bn 1.29 Bn
2 Viatris 19.12 Bn 18.23 Bn 1.46 Bn 1.45 Bn
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn 356.56 Mn
4 Amneal Pharmaceuticals 5.47 Bn 5.35 Bn 334.51 Mn 195.34 Mn
5 Bausch Health Companies 2.37 Bn 530.13 Mn 2.10 Bn 2.11 Bn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn -65.41 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 225.58 Mn
8 Amphastar Pharmaceuticals 991.81 Mn 701.69 Mn 93.47 Mn 53.74 Mn
9 Fennec Pharmaceuticals 412.12 Mn 370.87 Mn 17.15 Mn 16.14 Mn
10 RedHill Biopharma 182.76 Mn 182.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -65.41 Mn
Mar 31, 2026 -50.18 Mn
Dec 31, 2025 -138.24 Mn
Sep 30, 2025 -77.54 Mn
Jun 30, 2025 -81.46 Mn
Mar 31, 2025 -56.78 Mn
Dec 31, 2024 -237.03 Mn
Sep 30, 2024 -50.45 Mn
Jun 30, 2024 -61.68 Mn
Mar 31, 2024 -65.36 Mn
Dec 31, 2023 -287.39 Mn
Aug 31, 2023 -141.49 Mn
Jun 30, 2023 -68.43 Mn
Mar 20, 2023 -287.39 Mn
Dec 31, 2022 -367.36 Mn
Aug 31, 2022 -226.03 Mn
Jun 30, 2022 593.40 Mn
Mar 20, 2022 -367.36 Mn
Dec 31, 2021 -275.14 Mn
Sep 30, 2021 -76.15 Mn